February 22, 2022
dievini quits selling CureVac’s common shares to the public
dievini Hopp BioTech holding GmbH & Co. KG (dievini), DH-LT-Investments GmbH and Dietmar Hopp, as well as the managing directors…
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
February 22, 2022
TargED raises Series A financing of EUR 39 million to accelerate development of its lead compound
TargED Biopharmaceuticals (“TargED”), a private biotechnology company focused on developing improved treatments for thrombotic diseases, has announced it has raised…
February 22, 2022
Myricx Pharma announces senior team expansion with appointment of CMO, and Heads of Biology and Bioinformatics
Myricx Pharma (‘Myricx’), a drug discovery company focused on developing small molecule inhibitors that selectively target the human N-myristoyltransferases (NMT)…
February 21, 2022
Thermo Fisher Scientific launches new portfolio of chromatography and mass spectrometry consumables
Thermo Fisher Scientific has launched a new collection of caps, vials, inserts, kits, well plates and mats improves analytical performance…
February 21, 2022
Potentially life-saving treatment is safe to use for babies with neonatal sepsis, study reveals
GARDP (Global Antibiotic R&D Partnership) has announced that results from a clinical trial completed in Kenya have determined that a…
February 21, 2022
Molecule partners to develop Web3-based ecosystem addressing inefficiencies in biopharma R&D
Molecule, a biotech IP Web3 marketplace, has announced a tripartite partnership with Apollo Health Ventures, a longevity-focused venture capital fund,…
February 21, 2022
PrecisionLife appoints Colin Stubberfield as SVP Drug Discovery
PrecisionLife Limited has appointed Colin Stubberfield, Ph.D. as SVP Drug Discovery. He will be based at the company’s UK headquarters…
February 21, 2022
Valneva awarded up to £20 M by Scottish Enterprise to advance vaccine development
Valneva’s subsidiary Valneva Scotland has been awarded research and development funding of up to £20 million by Scottish Enterprise. The…
February 18, 2022
Recipharm acquires Vibalogics and Arranta Bio
Recipharm, a global contract development and manufacturing organisation (CDMO), has announced the acquisition of Vibalogics, a virotherapy CDMO and a…
February 18, 2022
Sandoz launches generic lenalidomide in 19 countries across Europe, expanding access to essential oncology medicine
Sandoz has announced the launch of generic oncology medicine lenalidomide, indicated for several haemato-oncology conditions as recommended by the latest…